sever
acut
respiratori
syndrom
sar
caus
newli
identifi
coronaviru
sarscov
remain
threat
caus
epidem
evidenc
recent
sporad
case
china
commun
evalu
efficaci
safeti
two
sar
vaccin
candid
base
recombin
modifi
vaccinia
ankara
mva
express
sarscov
spike
nucleocapsid
protein
ferret
clinic
sign
observ
ferret
challeng
sarscov
hand
vaccin
prevent
sarscov
infect
ferret
contrast
immun
ferret
particularli
immun
rmvaspik
exhibit
significantli
stronger
inflammatori
respons
focal
necrosi
liver
tissu
sarscov
challeng
control
anim
thu
data
suggest
enhanc
hepat
link
vaccin
rmva
express
sarscov
antigen
crown
first
worldwid
sever
acut
respiratori
syndrom
sar
epidem
late
first
half
caus
sever
stress
everi
aspect
societi
particularli
epidem
area
caus
agent
quickli
identifi
character
new
member
famili
coronavirida
sarsassoci
coronaviru
sarscov
evidenc
sporad
case
report
late
http
wwwwprowhointsarsdoc
pressreleasespr
http
wwwwhointcsr
sarscov
remain
constant
threat
caus
anoth
epidem
therefor
urgent
need
develop
effect
vaccin
contain
futur
sar
outbreak
present
studi
use
highli
attenu
vaccinia
viru
modifi
vaccinia
ankara
mva
vector
construct
recombin
mva
express
sarscov
spike
nucleocapsid
n
protein
analogu
two
major
antigen
protein
respons
induc
protect
immun
respons
coronavirus
sinc
report
ferret
suscept
sarscov
infect
use
ferret
anim
model
evalu
efficaci
safeti
rmva
base
sar
vaccin
vero
cell
use
grow
mva
kindli
provid
dr
bernard
moss
nih
isol
sarscov
isol
nml
respect
six
week
old
g
male
castrat
ferret
mustela
putoriu
furo
purchas
marshal
farm
pet
suppli
wolcott
new
york
anim
hous
anim
manipul
approv
anim
care
committe
canadian
scienc
centr
human
anim
health
met
canadian
council
anim
care
guidelin
sarscov
isol
n
gene
synthes
use
standard
rtpcr
protocol
sequenc
confirm
comparison
genbank
sequenc
access
number
nc
sarscov
n
gene
clone
vaccinia
recombin
express
vector
provid
dr
bernard
moss
nih
recombin
mva
express
rmva
n
rmvan
protein
select
mycophenol
acid
select
medium
use
standard
protocol
construct
recombin
poxvirus
anim
work
perform
biosafeti
level
immun
stage
challeng
stage
contain
laboratori
canadian
food
inspect
agenc
canadian
scienc
centr
human
anim
health
ferret
immun
plaqueformingunit
pfu
rmva
rmvan
parent
mva
control
pb
intraperiton
subcutan
rout
two
week
prime
immun
ferret
receiv
booster
immun
pfu
correspond
virus
pb
inocul
rout
anim
monitor
daili
blood
sampl
collect
day
day
post
vaccin
analyz
antibodi
respons
enzymelink
immunosorb
assay
elisa
microneutr
assay
four
week
prime
immun
ferret
challeng
pfu
isol
sarscov
intranas
rout
anim
monitor
temperatur
taken
daili
fece
oralthroat
swab
specimen
collect
daili
blood
sampl
taken
day
post
sarscov
challeng
anim
euthanis
day
challeng
sarscov
necropsi
perform
elisa
assay
sarscov
infect
mockinfect
cell
lysat
use
coat
elisa
plate
falcon
ferret
sera
heatinactiv
c
min
dilut
pb
contain
tween
skim
milk
triplic
hrp
conjug
secondari
antibodi
goat
antiferret
igg
purchas
immunolog
consult
laboratori
newberg
usa
abtsh
system
kpl
use
substrat
od
read
reaction
sera
sarscov
infect
cell
lysat
posit
control
mockinfect
lysat
neg
control
compar
positiveneg
pn
ratio
calcul
determin
elisa
result
mean
neg
pn
ratio
establish
use
total
sera
provid
marshal
farm
determin
standard
deviat
thu
elisa
data
pn
ratio
less
interpret
neg
ratio
greater
equal
interpret
posit
mprna
perform
essenti
previous
report
viral
rna
extract
blood
pharyng
swab
fece
use
tripur
isol
reagent
roch
two
set
primer
use
onestep
rtpcr
test
nucleocapsid
primersforward
primer
revers
primer
bni
polymeras
primer
develop
bernhardnocht
institut
tropic
medicin
hamburg
germani
http
wwwbnihamburgd
bni
forward
bni
outa
revers
sampl
ferret
receiv
sarscov
use
neg
control
viru
collect
infect
cell
supernat
use
posit
control
ferret
blood
sampl
analyz
level
alkalin
phosphatas
alanin
aminotransferas
albumin
creatinin
total
bilirubin
total
protein
urea
use
vettest
blood
chemistri
analyz
idexx
laboratori
inc
usa
reagent
suppli
manufactur
standard
histopatholog
procedur
use
prepar
formalin
fix
tissu
histopatholog
examin
tissu
stain
hematoxylin
eosin
express
sarscov
n
protein
confirm
western
blot
specif
monoclon
antibodi
sar
patient
serum
fig
ferret
sarscov
neg
base
serolog
rtpcr
test
perform
experi
twelv
ferret
divid
four
group
three
anim
immun
pb
parent
mva
rmva
rmvan
respect
shown
tabl
antibodi
detect
three
ferret
vaccin
rmva
booster
immun
elisa
neutral
activ
also
detect
sera
collect
day
booster
immun
rmva
viru
titr
declin
undetect
level
day
booster
microneutr
assay
tabl
comparison
detect
antibodi
respons
observ
ferret
receiv
rmvan
even
follow
booster
immun
sinc
report
ferret
suscept
sarscov
infect
challeng
vaccin
control
anim
pfu
sarscov
isol
intranas
rout
week
booster
immun
clinic
sign
elev
temperatur
alter
behaviour
includ
feed
observ
day
post
challeng
anim
data
shown
howev
viral
rna
detect
fece
pharyng
swab
blood
sampl
rtpcr
tabl
viral
rna
could
detect
pharyng
swab
fece
ferret
within
first
day
challeng
moreov
infecti
viru
could
isol
select
pharyng
swab
earli
infect
day
post
infect
data
shown
viral
rna
declin
fece
ferret
undetect
level
day
post
challeng
contrast
ferret
continu
shed
viru
pharyng
secret
day
post
challeng
fact
two
ferret
vaccin
rmvan
vaccin
rmva
still
shed
viru
pharyng
excret
day
post
challeng
interestingli
viral
rna
found
blood
specimen
day
post
challeng
except
ferret
pb
control
vaccin
howev
averag
viral
rna
persist
blood
longer
pharyng
excret
fece
except
ferret
viral
rna
detect
blood
whole
cours
studi
data
indic
sarscov
replic
ferret
replic
last
week
howev
studi
requir
elucid
kinet
viru
replic
ferret
antibodi
respons
challeng
sarscov
examin
elisa
mprnt
test
notabl
neutral
antibodi
respons
observ
sera
ferret
vaccin
rmva
earli
day
sarscov
challeng
neutral
antibodi
detect
ferret
day
sarscov
inocul
show
rapid
memori
immun
respons
occur
ferret
immun
rmva
follow
sarscov
challeng
furthermor
ferret
immun
rmva
develop
peak
neutral
antibodi
titr
day
post
challeng
sarscov
tabl
contrast
challeng
ferret
develop
compar
level
neutral
antibodi
day
sarscov
challeng
tabl
neutral
antibodi
respons
correspond
serum
igg
titr
determin
elisa
tabl
rapid
vigor
neutral
antibodi
respons
induc
immun
rmva
lead
prevent
sarscov
dissemin
evidenc
presenc
viru
clinic
specimen
tabl
although
obviou
clinic
sign
observ
follow
challeng
sarscov
biochem
test
blood
sampl
histolog
examin
variou
tissu
section
perform
investig
patholog
effect
consequ
rmva
vaccin
sarscov
challeng
use
vettest
dri
chemistri
analyz
idexx
laboratori
inc
usa
blood
sampl
taken
variou
time
point
examin
level
alkalin
phosphatas
indic
hepat
diseas
involv
biliari
system
alanin
aminotransferas
alt
indic
hepat
parenchym
lesion
albumin
indic
abnorm
hepat
renal
function
creatinin
indic
renal
diseas
total
bilirubin
indic
obstruct
liver
diseas
total
protein
indic
abnorm
hepat
renal
function
urea
indic
renal
diseas
surprisingli
ferret
vaccin
rmvan
rmva
demonstr
significantli
higher
level
alt
challeng
sarscov
control
ferret
fig
panel
ae
elev
level
alt
evidenc
day
post
sarscov
challeng
last
day
paramet
test
fell
normal
slightli
higher
alkalin
phophatas
physiolog
rang
compar
refer
valu
idexx
laboratori
inc
usa
data
shown
histopatholog
evalu
liver
tissu
reveal
anim
infect
sarscov
develop
periport
panlobular
hepat
correl
elev
alt
level
ferret
immun
rmva
develop
significantli
sever
lesion
includ
focal
liver
cell
necrosi
infect
anim
fig
particular
ferret
develop
rapid
vigor
antibodi
respons
sever
hepat
contrast
mild
hepat
observ
control
anim
receiv
parent
mva
pb
although
ferret
immun
rmvan
also
demonstr
elev
level
alt
one
ferret
develop
sever
hepat
control
anim
sever
rmva
immun
ferret
control
observ
post
mortem
mention
tissu
specimen
patholog
section
collect
post
mortem
day
challeng
alt
level
alreadi
declin
slightli
normal
rang
fig
panel
e
therefor
like
liver
inflamm
shown
fig
may
truli
reflect
sever
hepat
associ
rmva
rmvan
vaccin
sarscov
challeng
detail
patholog
examin
time
alt
level
highest
perform
futur
studi
correl
data
shown
tabl
viral
rna
found
tissu
collect
post
mortem
examin
day
challeng
organ
mildli
affect
sarscov
infect
data
shown
antibodydepend
enhanc
ade
viral
infect
describ
sever
virus
well
document
neutral
antibodi
induc
spike
protein
felin
infecti
periton
viru
fipv
also
coronaviru
fail
protect
cat
viru
challeng
contrari
antibodi
acquir
either
passiv
transfer
immun
serum
spike
protein
fipv
immun
recombin
vaccinia
viru
express
spike
protein
often
lead
acceler
infect
mechan
ade
viru
infect
recent
enhanc
suscept
fipv
also
link
immun
respons
induc
viru
membran
nucleocapsid
protein
codeliv
sarscov
shown
infect
hepatocyt
caus
hepat
human
therefor
observ
immun
rmva
induc
enhanc
hepat
ferret
sarscov
challeng
line
previou
report
ade
fipv
infect
failur
observ
detect
immun
respons
induc
rmvan
inconsist
link
rmvan
vaccin
enhanc
liver
inflamm
may
due
lack
optim
immun
regimen
experi
investig
improv
immun
respons
use
differ
immun
regimen
ferret
would
allow
post
mortem
examin
variou
time
point
vaccin
challeng
detail
analysi
immun
respons
immunohistolog
studi
aid
understand
link
immun
respons
induc
sarscov
antigen
enhanc
liver
inflamm
moreov
confirm
observ
vaccin
enhanc
hepat
ferret
challeng
sarscov
vaccin
strategi
eg
inactiv
vaccin
recombin
adenoviru
base
vaccin
subunit
vaccin
examin
similar
fashion
report
commun
conclus
would
like
summar
initi
evalu
rmva
base
sar
vaccin
follow
first
rmva
induc
rapid
vigor
neutral
antibodi
respons
ferret
challeng
sarscov
howev
neutral
antibodi
prevent
viru
infect
spread
second
vaccin
sarscov
andor
n
protein
may
lead
enhanc
patholog
sarscov
infect
liver
may
caus
damag
liver
third
although
sarscov
caus
clinic
diseas
ferret
result
suggest
ferret
may
use
model
evalu
safeti
vaccin
strategi
final
would
like
suggest
extra
caution
must
taken
futur
human
trial
sar
vaccin
due
potenti
organ
damag
result
immun
